Key pointsr Exercise in patients with hypertension can be accompanied by an abnormal cardiovascular response that includes attenuated blood flow and an augmented pressor response.r Endothelin-1, a very potent vasoconstrictor, is a key modulator of blood flow and pressure during in health and has been implicated as a potential cause of the dysfunction in hypertension.r We assessed the role of endothelin-1, acting through endothelin A (ET A ) receptors, in modulating the central and peripheral cardiovascular responses to exercise in patients with hypertension via local antagonism of these receptors during exercise.r ET A receptor antagonism markedly increased leg blood flow, vascular conductance, oxygen delivery, and oxygen consumption during exercise; interestingly, these changes occurred in the presence of reduced leg perfusion pressure, indicating that these augmentations were driven by changes in vascular resistance.r These data indicate that ET A receptor antagonism could be a viable therapeutic approach to improve blood flow during exercise in hypertension.Abstract Patients with hypertension can exhibit impaired muscle blood flow and exaggerated increases in blood pressure during exercise. While endothelin (ET)-1 plays a role in regulating blood flow and pressure during exercise in health, little is known about the role of ET-1 in the cardiovascular response to exercise in hypertension. Therefore, eight volunteers diagnosed with hypertension were studied during exercise with either saline or BQ-123 (ET A receptor antagonist) Jesse C. Craig completed his PhD at Kansas State University in 2018. He is currently a postdoctoral fellow in the Utah Vascular Research Laboratory under the tutelage of Professor Joel D. Trinity. This investigation was carried out as part of an NIH T32 fellowship through the Divisions of Cardiovascular Medicine and Geriatrics. Jesse is interested in how local factors (nitric oxide, reactive oxygen species, endothelin) influence oxygen delivery and utilization in health and disease. The long-term goal of his research is to gain a greater understanding of the mechanisms contributing to dysfunction at the vascular and skeletal muscle systems interface. infusion following a 2-week withdrawal of anti-hypertensive medications. The common femoral artery and vein were catheterized for drug infusion, blood collection and blood pressure measurements, and leg blood flow was measured by Doppler ultrasound. Patients exercised at both absolute (0, 5, 10, 15 W) and relative (40, 60, 80% peak power) intensities. BQ-123 increased blood flow at rest (79 ± 87 ml/min; P = 0.03) and augmented the exercise-induced hyperaemia at most intensities (80% saline: 3818±1222 vs. BQ-123: 4812±1469 ml/min; P = 0.001). BQ-123 reduced leg MAP at rest (−8 ± 4 mmHg; P < 0.001) and lower intensities (0-10 W; P < 0.05). Systemic diastolic blood pressure was reduced (0 W, 40%; P < 0.05), but systemic MAP was defended by an increased cardiac output. The exercise pressor response ( MAP) did not differ between conditions (80% sa...